DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM was reported 373 times

DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UREAPLASMA TEST POSITIVE 2 0.1538
1 VENOUS INTRAVASATION 1 0.0667
2 BILE OUTPUT 1 0.0588
3 NEONATAL INTESTINAL OBSTRUCTION 1 0.0455
4 DIPHTHERIA 2 0.0426
5 DIVERTICULAR FISTULA 1 0.0278
6 OESOPHAGEAL MUCOSAL DISSECTION 1 0.0256
7 LARYNGEAL CANCER STAGE I 1 0.0250
8 RETROPERITONEAL ABSCESS 3 0.0248
9 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 1 0.0154
10 LUNG ADENOCARCINOMA STAGE I 1 0.0139
11 BURKHOLDERIA INFECTION 1 0.0120
12 NEONATAL CHOLESTASIS 1 0.0119
13 VASCULAR RESISTANCE PULMONARY INCREASED 1 0.0116
14 HEPATOBLASTOMA 1 0.0103
15 INTESTINAL ATRESIA 1 0.0093
16 HYPERADRENALISM 1 0.0082
17 BURKHOLDERIA TEST POSITIVE 1 0.0081
18 PELVIC CYST 1 0.0073
19 SKIN MACERATION 1 0.0065
20 URINARY RETENTION POSTOPERATIVE 1 0.0061
21 PNEUMONITIS ASPIRATION 2 0.0058
22 GASTROSTOMY TUBE INSERTION 1 0.0052
23 GASTROSTOMY TUBE SITE COMPLICATION 1 0.0050
24 DYSBACTERIOSIS 1 0.0047
25 LYMPHOCELE 3 0.0045
26 GASTRIC MUCOSAL HYPERTROPHY 1 0.0040
27 PRIMARY AMYLOIDOSIS 1 0.0039
28 APPLICATION SITE MASS 1 0.0036
29 CONTRAST ENCEPHALOPATHY 1 0.0036
30 INTESTINAL DIAPHRAGM DISEASE 1 0.0036
31 BACTERIURIA 2 0.0035
32 WRONG PRODUCT STORED 1 0.0035
33 HAEMATOMA INFECTION 2 0.0035
34 LUNG INJURY 1 0.0033
35 ANAL SQUAMOUS CELL CARCINOMA 1 0.0032
36 DISTAL INTESTINAL OBSTRUCTION SYNDROME 1 0.0030
37 TONGUE EXFOLIATION 1 0.0028
38 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
39 VAGINAL FISTULA 1 0.0028
40 STREPTOCOCCAL BACTERAEMIA 3 0.0028
41 BACTERIAL DISEASE CARRIER 2 0.0027
42 OESOPHAGEAL INJURY 1 0.0026
43 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
44 INHIBITORY DRUG INTERACTION 4 0.0025
45 MASKED FACIES 1 0.0025
46 FISTULA OF SMALL INTESTINE 1 0.0024
47 ANAL SPHINCTER ATONY 1 0.0023
48 POST-TRAUMATIC PAIN 1 0.0022
49 BRAIN HYPOXIA 2 0.0020
50 TRANSPLANT EVALUATION 1 0.0020
51 VISCERAL CONGESTION 1 0.0020
52 FAECAL VOLUME INCREASED 1 0.0019
53 STENT OCCLUSION 1 0.0019
54 CLAUSTROPHOBIA 2 0.0018
55 MECHANICAL ILEUS 1 0.0018
56 HYPOCHLORAEMIA 2 0.0017
57 LYMPHATIC DISORDER 1 0.0017
58 DIAPHRAGMATIC PARALYSIS 1 0.0017
59 CONTRAST MEDIA ALLERGY 3 0.0016
60 MONOCYTOSIS 1 0.0016
61 EXTREMITY CONTRACTURE 1 0.0016
62 OBSTRUCTION GASTRIC 2 0.0016
63 ENTEROCOCCUS TEST POSITIVE 1 0.0015
64 KLEBSIELLA TEST POSITIVE 1 0.0015
65 SMALL INTESTINE ULCER 1 0.0015
66 LUNG TRANSPLANT REJECTION 1 0.0015
67 PERITONEAL HAEMORRHAGE 2 0.0014
68 FOREIGN BODY ASPIRATION 1 0.0014
69 PALMOPLANTAR KERATODERMA 1 0.0014
70 APALLIC SYNDROME 1 0.0014
71 ESCHAR 1 0.0014
72 CONTRAST MEDIA REACTION 3 0.0013
73 ELECTROMECHANICAL DISSOCIATION 1 0.0013
74 PYLORIC STENOSIS 1 0.0012
75 PUPIL FIXED 2 0.0012
76 GASTROINTESTINAL FISTULA 1 0.0011
77 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
78 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
79 SKIN TEST POSITIVE 1 0.0011
80 ANAL HAEMORRHAGE 3 0.0011
81 BLADDER SPASM 2 0.0011
82 ADENOCARCINOMA OF COLON 2 0.0011
83 ELECTROCARDIOGRAM CHANGE 1 0.0011
84 INTUSSUSCEPTION 1 0.0010
85 SPUTUM RETENTION 1 0.0010
86 TESTICULAR DISORDER 1 0.0010
87 ANAPHYLACTOID REACTION 4 0.0010
88 SMALL INTESTINAL STENOSIS 1 0.0009
89 ASPIRATION 10 0.0009
90 FAECALOMA 5 0.0009
91 PERIRECTAL ABSCESS 1 0.0009
92 AORTIC DILATATION 1 0.0009
93 SUBCLAVIAN VEIN THROMBOSIS 1 0.0009
94 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
95 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
96 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
97 CLOSTRIDIUM COLITIS 1 0.0008
98 RETROPERITONEAL HAEMORRHAGE 2 0.0008
99 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 1 0.0008
100 PLATELET DISORDER 2 0.0008
101 TESTICULAR SWELLING 1 0.0008
102 NECROTISING COLITIS 1 0.0008
103 SIALOADENITIS 1 0.0007
104 URETERIC OBSTRUCTION 1 0.0007
105 PORPHYRIA ACUTE 1 0.0007
106 PELVIC INFLAMMATORY DISEASE 1 0.0007
107 ORAL MUCOSAL EXFOLIATION 1 0.0007
108 CONTRAINDICATION TO MEDICAL TREATMENT 1 0.0007
109 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
110 FUNGAEMIA 1 0.0006
111 NEONATAL DISORDER 1 0.0006
112 CUSHINGOID 2 0.0006
113 POSTURE ABNORMAL 2 0.0006
114 VENA CAVA THROMBOSIS 1 0.0006
115 RECALLED PRODUCT 1 0.0006
116 SPLENIC INFARCTION 1 0.0006
117 JUGULAR VEIN THROMBOSIS 1 0.0006
118 INDURATION 1 0.0006
119 NEPHROPATHY TOXIC 6 0.0005
120 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
121 SPINAL CORD COMPRESSION 2 0.0005
122 CONCOMITANT DISEASE PROGRESSION 1 0.0005
123 LARGE INTESTINAL STENOSIS 1 0.0005
124 FOAMING AT MOUTH 1 0.0005
125 PERIPHERAL ISCHAEMIA 2 0.0005
126 SKIN INDURATION 1 0.0005
127 LUNG ABSCESS 1 0.0005
128 LYMPHOCYTOSIS 1 0.0005
129 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
130 GASTRIC BYPASS 1 0.0005
131 PERICARDIAL HAEMORRHAGE 1 0.0005
132 ILEUS PARALYTIC 2 0.0004
133 ORAL PRURITUS 1 0.0004
134 LOCALISED OEDEMA 2 0.0004
135 BILIRUBIN CONJUGATED INCREASED 1 0.0004
136 PULSE ABSENT 2 0.0004
137 KIDNEY TRANSPLANT REJECTION 2 0.0004
138 FAECAL INCONTINENCE 2 0.0004
139 ORAL INTAKE REDUCED 1 0.0004
140 PRODUCT PACKAGING CONFUSION 1 0.0004
141 THROMBOTIC MICROANGIOPATHY 4 0.0004
142 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 7 0.0004
143 RENAL TUBULAR NECROSIS 4 0.0004
144 BREATH SOUNDS ABNORMAL 2 0.0004
145 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
146 GASTROINTESTINAL TUBE INSERTION 1 0.0004
147 PHARYNGEAL OEDEMA 6 0.0004
148 PRODUCT ODOUR ABNORMAL 4 0.0004
149 PHARYNGOLARYNGEAL PAIN 2 0.0004
150 ANORECTAL DISCOMFORT 2 0.0004
151 ANGIONEUROTIC OEDEMA 1 0.0004
152 BLOOD SODIUM INCREASED 1 0.0004
153 LARGE INTESTINAL ULCER 1 0.0004
154 MULTIPLE USE OF SINGLE-USE PRODUCT 2 0.0004
155 SKIN HYPERTROPHY 1 0.0004
156 STATUS EPILEPTICUS 4 0.0004
157 OESOPHAGEAL STENOSIS 1 0.0004
158 PHARYNGEAL DISORDER 1 0.0003
159 ESCHERICHIA SEPSIS 1 0.0003
160 STRIDOR 1 0.0003
161 INFUSION SITE REACTION 1 0.0003
162 NEPHROGENIC SYSTEMIC FIBROSIS 1 0.0003
163 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
164 DUODENITIS 1 0.0003
165 SMALL INTESTINAL OBSTRUCTION 4 0.0003
166 ABDOMINAL ADHESIONS 1 0.0003
167 BREAST CANCER RECURRENT 1 0.0003
168 IRIDOCYCLITIS 1 0.0003
169 TESTICULAR PAIN 1 0.0003
170 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
171 SNEEZING 7 0.0003
172 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
173 ATELECTASIS 3 0.0003
174 UNRESPONSIVE TO STIMULI 8 0.0003
175 HYPOVENTILATION 1 0.0003
176 WALKING AID USER 2 0.0003
177 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
178 PEPTIC ULCER 1 0.0003
179 COLITIS ISCHAEMIC 2 0.0003
180 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
181 CLOSTRIDIAL INFECTION 1 0.0003
182 TACHYPNOEA 4 0.0003
183 ECCHYMOSIS 2 0.0003
184 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
185 LARGE INTESTINE PERFORATION 2 0.0003
186 CAROTID ARTERY STENOSIS 1 0.0003
187 EAR PRURITUS 1 0.0003
188 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
189 DIVERTICULUM 2 0.0003
190 FACIAL BONES FRACTURE 1 0.0003
191 STEVENS-JOHNSON SYNDROME 6 0.0003
192 MALNUTRITION 3 0.0003
193 THROAT CLEARING 1 0.0003
194 PROCEDURAL COMPLICATION 2 0.0003
195 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
196 RHINOVIRUS INFECTION 1 0.0003
197 PNEUMONIA FUNGAL 1 0.0003
198 ATRIAL FLUTTER 2 0.0003
199 MUSCLE HAEMORRHAGE 1 0.0002
200 GENERALISED OEDEMA 3 0.0002
201 GASTROINTESTINAL PERFORATION 1 0.0002
202 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
203 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
204 MULTI-ORGAN FAILURE 4 0.0002
205 CARDIAC MURMUR 2 0.0002
206 URINE OUTPUT DECREASED 2 0.0002
207 BLOOD CALCIUM INCREASED 2 0.0002
208 ABDOMINAL ABSCESS 1 0.0002
209 CYTOMEGALOVIRUS VIRAEMIA 1 0.0002
210 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
211 VASCULAR DEVICE INFECTION 1 0.0002
212 NEPHROGENIC ANAEMIA 1 0.0002
213 NEPHROPATHY 2 0.0002
214 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
215 HYPOVOLAEMIC SHOCK 1 0.0002
216 VULVOVAGINAL PAIN 1 0.0002
217 ENTEROCOCCAL INFECTION 1 0.0002
218 HEPARIN-INDUCED THROMBOCYTOPENIA 1 0.0002
219 PANCREATIC DISORDER 1 0.0002
220 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
221 HYPERNATRAEMIA 1 0.0002
222 AMMONIA INCREASED 1 0.0002
223 PHLEBITIS 1 0.0002
224 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 1 0.0002
225 PRODUCT COLOUR ISSUE 1 0.0002
226 SKIN NECROSIS 1 0.0002
227 CYANOSIS 3 0.0002
228 FOOD CRAVING 1 0.0002
229 RENAL PAIN 2 0.0002
230 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
231 URTICARIA 31 0.0002
232 FAECES DISCOLOURED 4 0.0002
233 INTESTINAL ISCHAEMIA 1 0.0002
234 HYPERKERATOSIS 1 0.0002
235 INTRACRANIAL PRESSURE INCREASED 1 0.0002
236 ACUTE PULMONARY OEDEMA 1 0.0002
237 CHOLECYSTITIS ACUTE 1 0.0002
238 GENERALISED ERYTHEMA 1 0.0002
239 PRODUCT LABEL CONFUSION 1 0.0002
240 HYPOVOLAEMIA 1 0.0002
241 SPLENOMEGALY 2 0.0002
242 BACTERAEMIA 2 0.0002
243 POLYNEUROPATHY 2 0.0002
244 HEPATITIS CHOLESTATIC 1 0.0002
245 LARYNGEAL OEDEMA 1 0.0002
246 PRE-EXISTING CONDITION IMPROVED 1 0.0002
247 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
248 CARDIAC FLUTTER 1 0.0002
249 POOR QUALITY DRUG ADMINISTERED 1 0.0002
250 EXPIRED PRODUCT ADMINISTERED 5 0.0002
251 METASTASES TO LYMPH NODES 1 0.0001
252 RASH ERYTHEMATOUS 7 0.0001
253 PERITONITIS 3 0.0001
254 ANAPHYLACTIC REACTION 8 0.0001
255 HYPOGLYCAEMIA 7 0.0001
256 CARDIO-RESPIRATORY ARREST 6 0.0001
257 RIGHT VENTRICULAR FAILURE 1 0.0001
258 PAPULE 1 0.0001
259 RENAL FAILURE ACUTE 6 0.0001
260 SINUS TACHYCARDIA 2 0.0001
261 METASTASIS 1 0.0001
262 PRODUCT SUPPLY ISSUE 1 0.0001
263 PRURITUS GENERALISED 3 0.0001
264 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
265 GASTROENTERITIS 2 0.0001
266 ASCITES 4 0.0001
267 BLINDNESS TRANSIENT 1 0.0001
268 HYPOPHOSPHATAEMIA 1 0.0001
269 PULMONARY OEDEMA 6 0.0001
270 HYDRONEPHROSIS 1 0.0001
271 HEPATOCELLULAR CARCINOMA 1 0.0001
272 HYPERTHERMIA 1 0.0001
273 RENAL FAILURE CHRONIC 1 0.0001
274 ATRIOVENTRICULAR BLOCK 1 0.0001
275 GASTROINTESTINAL INFLAMMATION 1 0.0001
276 MEDICATION ERROR 7 0.0001
277 ULCER 2 0.0001
278 ABSCESS 2 0.0001
279 TRANSPLANT REJECTION 1 0.0001
280 STENT PLACEMENT 1 0.0001
281 BLOOD POTASSIUM INCREASED 2 0.0001
282 ABNORMAL FAECES 1 0.0001
283 NO ADVERSE EVENT 22 0.0001
284 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
285 HAEMODIALYSIS 1 0.0001
286 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
287 FACE OEDEMA 2 0.0001
288 CANDIDA INFECTION 2 0.0001
289 HAEMATEMESIS 3 0.0001
290 SCAR 2 0.0001
291 PSEUDOMONAS INFECTION 1 0.0001
292 ANAPHYLACTIC SHOCK 3 0.0001
293 MUSCULOSKELETAL DISCOMFORT 2 0.0001
294 GASTRITIS 3 0.0001
295 TUMOUR LYSIS SYNDROME 1 0.0001
296 PRODUCT COMMUNICATION ISSUE 1 0.0001
297 LUNG INFILTRATION 1 0.0001
298 PURPURA 1 0.0001
299 RESPIRATORY RATE INCREASED 1 0.0001
300 OROPHARYNGEAL DISCOMFORT 1 0.0001
301 END STAGE RENAL DISEASE 2 0.0001
302 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
303 GRAND MAL CONVULSION 1 0.0001
304 SEPSIS 12 0.0001
305 BACTERIAL INFECTION 2 0.0001
306 HEPATIC ENCEPHALOPATHY 1 0.0001
307 DEFORMITY 1 0.0001
308 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
309 LIVER FUNCTION TEST ABNORMAL 3 0.0001
310 HEPATOMEGALY 1 0.0001
311 HYPOTONIA 1 0.0001
312 BRAIN INJURY 1 0.0001
313 PRODUCT PHYSICAL ISSUE 2 0.0001
314 PLEURAL EFFUSION 6 0.0001
315 DRUG ADMINISTRATION ERROR 3 0.0001
316 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
317 PRODUCT PREPARATION ERROR 2 0.0001
318 SWOLLEN TONGUE 3 0.0001
319 RESPIRATORY FAILURE 7 0.0001
320 TENDERNESS 1 0.0001
321 INCONTINENCE 1 0.0001
322 BRADYCARDIA 5 0.0001
323 BREAST CANCER METASTATIC 1 0.0001
324 DECREASED ACTIVITY 1 0.0001
325 LACTIC ACIDOSIS 3 0.0001
326 SEPTIC SHOCK 4 0.0001
327 STAPHYLOCOCCAL INFECTION 3 0.0001
328 SYNCOPE 9 0.0001
329 PANCYTOPENIA 5 0.0001
330 EYE PRURITUS 3 0.0001
331 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
332 THROAT IRRITATION 4 0.0001
333 INTESTINAL PERFORATION 1 0.0001
334 BLOOD CALCIUM DECREASED 1 0.0001
335 MYOCARDIAL ISCHAEMIA 1 0.0001
336 MYOCARDITIS 1 0.0001
337 SHOCK 2 0.0001
338 GASTRIC HAEMORRHAGE 1 0.0001
339 EYELID OEDEMA 1 0.0001
340 VASCULITIS 1 0.0001
341 HYPOXIA 3 0.0001
342 LYMPHADENOPATHY 3 0.0001
343 ACCIDENTAL OVERDOSE 3 0.0001
344 NO THERAPEUTIC RESPONSE 1 0.0001
345 RESTLESSNESS 3 0.0001
346 ILEUS 1 0.0001
347 PNEUMONIA ASPIRATION 2 0.0001
348 LEUKOPENIA 4 0.0001
349 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
350 RASH GENERALISED 2 0.0001
351 HAEMATOMA 2 0.0001
352 SWELLING FACE 5 0.0001
353 CHILLS 9 0.0001
354 NODULE 1 0.0001
355 INCORRECT PRODUCT STORAGE 1 0.0001
356 FEBRILE NEUTROPENIA 5 0.0001
357 FREQUENT BOWEL MOVEMENTS 2 0.0001
358 BLOOD BILIRUBIN INCREASED 2 0.0001
359 SINUS CONGESTION 1 0.0001
360 THROAT TIGHTNESS 2 0.0001
361 PRODUCT TASTE ABNORMAL 1 0.0001
362 OEDEMA PERIPHERAL 9 0.0001
363 OEDEMA 4 0.0001
364 PERIPHERAL COLDNESS 1 0.0001
365 RESPIRATORY ARREST 2 0.0001
366 RESPIRATORY DISTRESS 2 0.0001
367 OXYGEN SATURATION DECREASED 4 0.0001
368 DEVICE OCCLUSION 1 0.0001
369 SKIN REACTION 1 0.0001
370 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
371 DIALYSIS 1 0.0001
372 LOSS OF CONSCIOUSNESS 9 0.0001
373 BRONCHOSPASM 1 0.0001
374 PARAESTHESIA ORAL 1 0.0001
375 MYELODYSPLASTIC SYNDROME 1 0.0001
376 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
377 INJECTION SITE HAEMATOMA 1 0.0001
378 CARDIOMYOPATHY 1 0.0001
379 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
380 URINARY INCONTINENCE 2 0.0001
381 ABDOMINAL DISTENSION 7 0.0001
382 BONE LOSS 1 0.0001
383 BLOOD POTASSIUM DECREASED 2 0.0001
384 HYPOAESTHESIA ORAL 1 0.0001
385 HEPATIC FAILURE 2 0.0001
386 CORONARY ARTERY DISEASE 2 0.0001
387 ECONOMIC PROBLEM 1 0.0001
388 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
389 SKIN DISCOLOURATION 3 0.0001
390 DEVICE RELATED INFECTION 1 0.0001
391 EJECTION FRACTION DECREASED 1 0.0001
392 OCULAR HYPERAEMIA 3 0.0001
393 COMA 3 0.0001
394 BLOOD CREATININE INCREASED 4 0.0001
395 CARDIAC ARREST 5 0.0001
396 HEART RATE INCREASED 6 0.0001
397 VENTRICULAR TACHYCARDIA 1 0.0001
398 LIP SWELLING 2 0.0001
399 COAGULOPATHY 1 0.0001
400 SKIN DISORDER 2 0.0001
401 HAEMATURIA 2 0.0001
402 ORTHOSTATIC HYPOTENSION 1 0.0001
403 EOSINOPHILIA 1 0.0001
404 BURNING SENSATION 4 0.0001
405 HEART RATE DECREASED 2 0.0001
406 PANCREATITIS 3 0.0001
407 DEPRESSED MOOD 3 0.0001
408 COLD SWEAT 1 0.0001
409 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
410 DRUG ERUPTION 1 0.0001
411 TACHYCARDIA 5 0.0001
412 THIRST 1 0.0001
413 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
414 HYPOTENSION 11 0.0001
415 DYSURIA 2 0.0001
416 EYE SWELLING 2 0.0001
417 HEPATIC STEATOSIS 1 0.0001
418 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
419 HYPONATRAEMIA 3 0.0001
420 HEPATIC CIRRHOSIS 1 0.0001
421 PHOTOPHOBIA 1 0.0001
422 INTESTINAL OBSTRUCTION 2 0.0001
423 COLITIS 2 0.0001
424 FOOT FRACTURE 1 0.0001
425 ANAEMIA 10 0.0001
426 SLEEP APNOEA SYNDROME 1 0.0001
427 CONTUSION 5 0.0001
428 HERNIA 1 0.0001
429 DYSTONIA 1 0.0001
430 PRODUCT QUALITY ISSUE 7 0.0001
431 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
432 SKIN FISSURES 1 0.0001
433 BLOOD PRESSURE ABNORMAL 1 0.0001
434 PRURITUS 19 0.0000
435 NEUTROPHIL COUNT DECREASED 2 0.0000
436 BODY TEMPERATURE INCREASED 1 0.0000
437 VOMITING 23 0.0000
438 PULMONARY HYPERTENSION 1 0.0000
439 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
440 IRRITABLE BOWEL SYNDROME 1 0.0000
441 POOR QUALITY SLEEP 1 0.0000
442 DEVICE LEAKAGE 2 0.0000
443 RASH MACULO-PAPULAR 1 0.0000
444 GLOSSODYNIA 1 0.0000
445 RASH PAPULAR 1 0.0000
446 PANCREATITIS ACUTE 1 0.0000
447 HYPOKALAEMIA 2 0.0000
448 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
449 ABDOMINAL PAIN 10 0.0000
450 ARRHYTHMIA 2 0.0000
451 PULMONARY EMBOLISM 4 0.0000
452 PRODUCTIVE COUGH 2 0.0000
453 DIARRHOEA 27 0.0000
454 PRESYNCOPE 1 0.0000
455 NEURALGIA 1 0.0000
456 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
457 GASTRIC CANCER 1 0.0000
458 ACUTE KIDNEY INJURY 6 0.0000
459 SKIN ULCER 1 0.0000
460 MUCOSAL INFLAMMATION 1 0.0000
461 PARAESTHESIA 6 0.0000
462 RENAL FAILURE 5 0.0000
463 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
464 JAUNDICE 1 0.0000
465 RASH PRURITIC 2 0.0000
466 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
467 PALLOR 1 0.0000
468 SKIN LESION 1 0.0000
469 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
470 MENTAL STATUS CHANGES 1 0.0000
471 HAEMOPTYSIS 1 0.0000
472 RENAL IMPAIRMENT 3 0.0000
473 BLISTER 2 0.0000
474 SKIN EXFOLIATION 3 0.0000
475 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
476 DYSSTASIA 1 0.0000
477 DYSPHONIA 2 0.0000
478 BONE PAIN 2 0.0000
479 ERYTHEMA 7 0.0000
480 INSOMNIA 9 0.0000
481 OESOPHAGEAL CARCINOMA 1 0.0000
482 RESPIRATORY DISORDER 1 0.0000
483 HYPOAESTHESIA 5 0.0000
484 IRRITABILITY 2 0.0000
485 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
486 DISCOMFORT 2 0.0000
487 FEELING HOT 2 0.0000
488 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
489 EXPOSURE DURING PREGNANCY 2 0.0000
490 HEAD INJURY 1 0.0000
491 DRUG INTERACTION 5 0.0000
492 HYPOTHYROIDISM 1 0.0000
493 HYPERHIDROSIS 4 0.0000
494 RHINORRHOEA 2 0.0000
495 DEEP VEIN THROMBOSIS 2 0.0000
496 CHOLELITHIASIS 1 0.0000
497 DYSPEPSIA 3 0.0000
498 IMPAIRED HEALING 1 0.0000
499 OSTEONECROSIS 1 0.0000
500 NAUSEA 24 0.0000
501 INFUSION RELATED REACTION 2 0.0000
502 VISUAL ACUITY REDUCED 1 0.0000
503 URINARY RETENTION 1 0.0000
504 GAIT INABILITY 1 0.0000
505 RASH 13 0.0000
506 ABDOMINAL DISCOMFORT 5 0.0000
507 TYPE 2 DIABETES MELLITUS 1 0.0000
508 NEUTROPENIA 4 0.0000
509 HAEMOGLOBIN DECREASED 3 0.0000
510 GASTRIC DISORDER 1 0.0000
511 DELIRIUM 1 0.0000
512 NEOPLASM PROGRESSION 1 0.0000
513 COUGH 8 0.0000
514 INJURY 2 0.0000
515 HYPERTENSION 6 0.0000
516 DYSPNOEA 16 0.0000
517 PLATELET COUNT DECREASED 3 0.0000
518 CEREBRAL HAEMORRHAGE 1 0.0000
519 CONSTIPATION 6 0.0000
520 C-REACTIVE PROTEIN INCREASED 1 0.0000
521 HYPERGLYCAEMIA 1 0.0000
522 AGITATION 2 0.0000
523 DYSARTHRIA 1 0.0000
524 HALLUCINATION 2 0.0000
525 CHRONIC KIDNEY DISEASE 2 0.0000
526 PALPITATIONS 3 0.0000
527 DISORIENTATION 1 0.0000
528 CARDIAC FAILURE CONGESTIVE 2 0.0000
529 THROMBOSIS 2 0.0000
530 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
531 PNEUMONIA 8 0.0000
532 BLINDNESS 1 0.0000
533 OSTEOPOROSIS 1 0.0000
534 ABDOMINAL PAIN UPPER 5 0.0000
535 POLLAKIURIA 1 0.0000
536 ANGIOEDEMA 1 0.0000
537 GASTROINTESTINAL DISORDER 2 0.0000
538 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
539 MEMORY IMPAIRMENT 3 0.0000
540 NEPHROLITHIASIS 1 0.0000
541 OROPHARYNGEAL PAIN 2 0.0000
542 DECREASED APPETITE 5 0.0000
543 BACK PAIN 5 0.0000
544 BREAST CANCER 2 0.0000
545 ATRIAL FIBRILLATION 2 0.0000
546 PYREXIA 7 0.0000
547 CELLULITIS 1 0.0000
548 OFF LABEL USE 17 0.0000
549 HAEMORRHAGE 2 0.0000
550 SPEECH DISORDER 1 0.0000
551 DRUG EFFECT DECREASED 1 0.0000
552 HAEMATOCHEZIA 1 0.0000
553 TREMOR 3 0.0000
554 ARTHROPATHY 1 0.0000
555 INFLUENZA 2 0.0000
556 URINARY TRACT INFECTION 3 0.0000
557 CONVULSION 1 0.0000
558 NASAL CONGESTION 1 0.0000
559 PAIN IN EXTREMITY 5 0.0000
560 CATARACT 1 0.0000
561 EMOTIONAL DISTRESS 2 0.0000
562 STOMATITIS 1 0.0000
563 MUSCLE SPASMS 3 0.0000
564 CHEST PAIN 3 0.0000
565 HYPERSENSITIVITY 3 0.0000
566 VISUAL IMPAIRMENT 2 0.0000
567 BLOOD PRESSURE DECREASED 1 0.0000
568 DEHYDRATION 2 0.0000
569 HEPATIC ENZYME INCREASED 1 0.0000
570 PAIN 9 0.0000
571 SLEEP DISORDER 1 0.0000
572 ANXIETY 4 0.0000
573 MOBILITY DECREASED 1 0.0000
574 INFECTION 2 0.0000
575 DYSGEUSIA 1 0.0000
576 ASTHENIA 5 0.0000
577 CONDITION AGGRAVATED 4 0.0000
578 INCORRECT DOSE ADMINISTERED 3 0.0000
579 BLOOD PRESSURE INCREASED 2 0.0000
580 DRUG INEFFECTIVE 17 0.0000
581 CARDIAC FAILURE 1 0.0000
582 CONFUSIONAL STATE 2 0.0000
583 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
584 INFLUENZA LIKE ILLNESS 1 0.0000
585 ARTHRALGIA 5 0.0000
586 ADVERSE EVENT 1 0.0000
587 WEIGHT DECREASED 3 0.0000
588 CARDIAC DISORDER 1 0.0000
589 SWELLING 1 0.0000
590 DYSPHAGIA 1 0.0000
591 THROMBOCYTOPENIA 1 0.0000
592 MUSCULAR WEAKNESS 1 0.0000
593 DEPRESSION 2 0.0000
594 DISEASE PROGRESSION 1 0.0000
595 DIZZINESS 4 0.0000
596 HEADACHE 5 0.0000
597 FATIGUE 6 0.0000
598 DRY SKIN 1 0.0000
599 DEATH 6 0.0000
600 MALAISE 3 0.0000
601 PERIPHERAL SWELLING 1 0.0000
602 CEREBROVASCULAR ACCIDENT 1 0.0000
603 MYOCARDIAL INFARCTION 1 0.0000
604 NASOPHARYNGITIS 1 0.0000
605 PRODUCT USE ISSUE 1 0.0000
606 GAIT DISTURBANCE 1 0.0000
607 SOMNOLENCE 1 0.0000
608 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
609 OVERDOSE 1 0.0000
610 FEELING ABNORMAL 1 0.0000
611 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
612 PRODUCT DOSE OMISSION ISSUE 1 0.0000
613 FALL 1 0.0000